- Home
- BLRX vs QNME Comparison
BLRX vs QNME Comparison
Compare BLRX & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLRX | QNME |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated Freight & Logistics |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 11.4M |
| IPO Year | 2010 | 2024 |
Fundamental Metrics
Financial Performance| Metric | BLRX | QNME |
|---|---|---|
| Price | $2.51 | $0.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | 17.4K | ★ 599.3K |
| Earning Date | 05-26-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $18,315,155.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 42.28 |
| 52 Week Low | $2.15 | $0.30 |
| 52 Week High | $4.56 | $0.59 |
Technical Indicators
Market Signals| Indicator | BLRX | QNME |
|---|---|---|
| Relative Strength Index (RSI) | 41.54 | 36.07 |
| Support Level | $2.18 | $0.31 |
| Resistance Level | $3.08 | $0.37 |
| Average True Range (ATR) | 0.23 | 0.03 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 4.45 | 17.78 |
Price Performance
Historical ComparisonAbout BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About QNME Quanome Technologies Inc. Common Stock
Quanome Technologies Inc is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea.